Clinical Trial: Effect of Alpelisib in Healthy Volunteers
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Insulin Resistance
Study Type: INTERVENTIONAL
Official Title: Insulin Resistance in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Alpelisib Pilot & Feasibility Study
Brief Summary:
The goal of this clinical trial is to test a single dose of the phosphoinositide-3-kinase (PI3K) inhibitor alpelisib versus placebo in healthy volunteers.The main questions it aims to answer are the impact of acute alpelisib-induced insulin resistance on parameters of glucose and lipid metabolism (how healthy people respond to temporary insulin resistance so that the investigators can see what happens to how the liver handles fat and sugar).Participants will:Consume their total calculated daily caloric needs in…
Read more